Characterization of pregnant women with immature necks treated with Misofar as a cervical remodeler
Keywords:
pregnant, Misofar, cervix, apgar scoreAbstract
Introduction: Throughout history, different methods have been introduced to ripen the cervix and trigger childbirth. This list includes Misofar, an essential drug in the induction of labor.
Objective: Characterize pregnant women with immature necks treated with Misofar as a cervical remodeler.
Methods: A descriptive, cross-sectional study was carried out at the Maternal Hospital of Camaguey, during the year 2021. The population under study was made up of 275 pregnant women with immature necks treated with Misofar, treated at the aforementioned institution. The variables analyzed were: age, number of deliveries, time of use of Misofar, use of the combined method, Bishop's Index, failure of the combined method, route of delivery, amniotic fluid, weight of the newborn, maternal and perinatal complications, score of Apgar at one minute and five minutes.
Results: Pregnant women between 20-24 years of age (38.2%), nulliparous (65.5%) predominated, while 39.3% required a single dose. The 76.4% had a eutocic delivery, with clear amniotic fluid (63.3%). There was a preponderance of newborns weighing between 3001-3500 grams (43.6%), while 96.0% did not present complications. In relation to the Apgar score at one minute and five minutes, it showed that in 84.0% of the pregnant women there were no aggravations.
Conclusions: Misofar's main characteristics are its affectiveness in the maturity of the cervix and the onset of labor. Maternal and perinatal complications occur in a small number of patients.
References
1. Figueroa Mego BR. Efectividad de la inducción del parto a través del uso de sonda foley y oxitocina vs oxitocina sola en el HNDAC 2016-2018.Repositorio institucional de la Universidad Ricardo Palma de Perú [Internet]. 2020 [acceso: 01/10/2023]: [aprox. 96 p.]. Disponible en: https://hdl.handle.net/20.500.14138/2998
2. Fuenmayor Beltrán M,Reyna Villasmil E, Santos Bolívar J, Mejia MontillaJ, Reyna Villasmil N, Fernández Ramírez A. Sonda de Foley transcervical oxitocina u oxitocina sola para la inducción del parto en embarazos a término. Rev Perú ginecol obstet [Internet]. 2019 [acceso: 01/10/2023];63(2): [aprox.11 p.]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322017000200006
3. Aragón Hernández JP, Ávila Vergara MA, Beltrán Montoya J, Calderón Cisneros E, Caldiño Soto F, Castilla Zenteno A, et al. Protocolo clínico para inducción del trabajo de parto: propuesta de consenso. Ginecol Obstet Mex [Internet]. 2019 [acceso: 01/10/2023];85(5): [aprox.11 p.]. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2017/gom175f.pdf
Nápoles Méndez D. El Misofar® como prostaglandina facilitadora: una nueva opción en obstetricia. MEDISAN [Internet]. 2020 [acceso: 01/10/2023];21(9):[aprox.12 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192017000900011
4. Organización Mundial de la Salud. Safe Abortion: Technical and Policy Guidance for Health Systems. 2ª ed. Génova. OMS [Internet]. 2019 [acceso: 01/10/2023]: [aprox. 4 p.]. Disponible en:https://oms.induccion-del-trabajo-de-parto.12-22.2019
5. Bach de la Peña Martínez, ML. Nivel de conocimiento sobre el uso y efecto materno-perinatal del análogo semisintético de la prostaglandina E1; en las internas de obstetricia del Hospital Regional Docente Materno Infantil “El Carmen” Huancayo –2017, Huancayo, Perú. Repositorio institucional de la Universidad Privada de Huancayo “Franklin Roosevelt”. [Internet]. 2020 [acceso: 01/10/2023]: [aprox. 68 p.]. Disponible en: http://repositorio.uroosevelt.edu.pe/xmlui/handle/ROOSEVELT/51
6. Nápoles MéndezD, Piloto Padrón M. Misofar® en el periparto. MEDISAN [Internet]. 2016 [acceso: 01/10/2023];20(7): [aprox. 12 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016000700016
8. Vilató de Varona OL. Uso del Misofar o Misoprostol en embarazadas. Camagüey: Periódico Adelante [Internet]. 2019 [acceso: 01/10/2023]: [aprox. 2 p.]. Disponible en: http://www.adelante.cu/index.php/es/consultas-medicas/14595-uso-del-misofar-o-misoprostol-en-embarazadas
9. Vera Loyola EM. Maduración cervical con misoprostol en relación a la vía de culminación del parto en gestantes de 41 semanas. HONADOMANI San Bartolomé enero 2005 diciembre 2009, Lima, Perú. Repositorio institucional de la Universidad Nacional Mayor de San Marcos [Internet]. 2020 [acceso: 01/10/2023]: [aprox. 91 p.]. Disponible en: https://cybertesis.unmsm.edu.pe/bitstream/handle/20.500.12672/14004/Vera_le.pdf?sequence=3
10. Scapin Soliane Q. Inducción del trabajo de parto en un hospital Universitario. Texto Contexto Enferm [Internet]. 2020 [acceso: 01/10/2023];27(1): e0710016. Disponible en:https://www.scielo.br/j/tce/a/cCpfS7xth6BTZK5h4cRdwqv/abstract/?lang=es
11. Terán Becerra YO. Uso de misoprostol y oxitocina en la Inducción del trabajo de parto asociados a complicaciones materno fetales. Hospital Regional Docente de Cajamarca. 2017.Repositorio institucional del Hospital Regional Docente de Cajamarca. [Internet]. 2017 [acceso: 01/10/2023] [aprox. 73 p.]. Disponible en:http://repositorio.unc.edu.pe/bitstream/handle/UNC/1448/TESIS%20Uso%20de%20Misoprostol%20y%20Oxitocina%20asociadoa%20a%20Complicaciones.pdf?sequence=1&isAllowed=y
12. Velásquez Rocha AL. Uso de misoprostol vía vaginal, para maduración cervical, en pacientes con embarazo ≥37 semanas ingresadas en ARO II, Hospital Escuela Oscar Danilo Rosales Arguello, junio 2016-junio 2018. Repositorio institucional de la Facultad de Ciencias Médicas, Unan- León. [Internet]. 2019 [acceso: 01/10/2023]: [aprox. 80 p.]. Disponible en:http://riul.unanleon.edu.ni:8080/jspui/handle/123456789/7049
13. Cárcamo JA, Maldonado M, Navarro L. Misoprostol para Maduración Cervical e Inducción del Trabajo de Parto. Rev Méd Hondureña. [Internet]. 1994 [acceso: 01/10/2023];62(5):3-11. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-139876
14. Ashwal E, Krispin E, Aviram A, Aleyraz E, Gabby Benziv R, Wiznitzer A, et al. Perinatal outcome in women with prolonged premature rupture of membranes at term undergoing labor induction. Arch Gynecol Obstet [Internet]. 2019 [acceso: 01/10/2023]; 94:1125-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27234507/
15. Deshmukh VL, Rajamanya AV, Yelikar KA. Oral misoprostol solution for induction of labour. J Obstet Gynaecol India. [Internet]. 2019 [acceso: 01/10/2023];67(2):98-103. Disponible en: https://pubmed.ncbi.nlm.nih.gov/pmc/articles/PMC6513439/
16. Tenore JL. Methods for cervical ripening and induction of labor. Am Fam Physician. [Internet]. 2003 [acceso: 01/10/2023];67(10):2123-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9107114
17. Bishop EH. Pelvic scoring for elective induction. Obstet gynecol [Internet]. 2019 [acceso: 01/10/2023];24(2):266-8. Disponible en:https://embryo.asu.edu/pages/pelvic-scoring-elective-induction-1964-edward-bishop
18. Hannah ME, Ohlsson A, Farine D Et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med [Internet]. 2019 [acceso: 01/10/2023];334(1):1005-10. Disponible en:https://pubmed.ncbi.nlm.nih.gov/8598837/
19. Macotela Aycho NG. Induction of labor with misoprostol and maternal fetal complications in patients treated at Nasca Support Hospital from October 2014 to April 2016. Repositorio institucional Nasca Support Hospital. [Internet]. 2019 [acceso: 01/10/2023]: [aprox. 56 p.]. Disponible en: http://repositorio.uap.edu.pe/handle/uap/4946
20. Montalvan Gago HI. Características perinatales del recién nacido de madre adolescente, servicio de neonatología del Hospital Sergio Bernales enero-diciembre 2016. Repositorio institucional de la Universidad privada San Juan Bautista. [Internet]. 2017 [acceso: 01/10/2023]. Disponible en: https://repositorio.upsjb.edu.pe/handle/20.500.14308/543
21. Benítez Guerra G, Conno Alaya A de. Inducción del trabajo de parto con Misoprostol oral y vaginal. Rev Fac Med [Internet]. 2007 [acceso: 01/10/2023];30(1):1-9. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0798-04692007000100010&Ing=es.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rolando Rodríguez Puga
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain copyright and all unrestricted publication rights.
Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The license cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
